Kingdon Capital Management, L.L.C. Kempharm, Inc Transaction History
Kingdon Capital Management, L.L.C.
- $673 Million
- Q3 2025
A detailed history of Kingdon Capital Management, L.L.C. transactions in Kempharm, Inc stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 650,000 shares of KMPH stock, worth $3.21 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
650,000
Previous 450,000
44.44%
Holding current value
$3.21 Million
Previous $2.22 Million
44.44%
% of portfolio
0.48%
Previous 0.35%
Shares
2 transactions
Others Institutions Holding KMPH
# of Institutions
180Shares Held
37MCall Options Held
4.78MPut Options Held
1.25M-
Woodline Partners LP San Francisco, CA3.48MShares$17.2 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.08MShares$15.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.23MShares$11 Million0.02% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.97MShares$9.74 Million0.39% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...